Riyadh — Mubasher: Scientific & Medical Equipment House Company’s board of directors recommended on 20 September 2026 the repurchase of up to 3 million ordinary shares.
The proposed buyback represents 10% of the company’s total shares and is intended to be held as treasury stock.
The board stated that the primary motivation for the transaction is the view that the current market price of the stock is lower than its fair value.
According to the regulatory filing, the company currently holds 0% of its shares as treasury stock. The acquisition will be financed through the internal resources of the firm.
The execution of the buyback is subject to approval from the extraordinary general meeting (EGM) and must meet the financial solvency requirements stipulated in the Implementing Regulations of the Companies Law for Listed Joint Stock Companies.
Shares purchased by the company will not carry voting rights in shareholder assembly meetings.
Further details regarding the timeline of the purchase will be disclosed following the necessary approvals.
